期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 20, 期 -, 页码 1-55出版社
ELSEVIER SCI LTD
DOI: 10.1111/1469-0691.12427
关键词
Acinetobacter; Burkholderia; Enterobacteriaceae; extended-spectrum -lactamase; guideline; infection control; multidrug-resistant Gram-negative; outbreak; Pseudomonas; Stenotrophomonas
资金
- Italian Department of Culture, University and Research, Universita Cattolica, Rome, Italy
- German Center for Infectious Research (DZIF)
- Durata
- Waters
- Novartis
- Pfizer
- European Commission
- English Department of Health
- Healthcare Infection Society
- European Centre for Disease Control
- Ecolab
- CareFusion
- Sanofi Pasteur
- Janssen-Cilag
- MSD
- Astellas Pharma
- Becton Dickinson
- Jannssen
- Johnson Johnson
- Spanish Network for Research in Infectious Diseases (REIPI)
- Instituto de Salud Carlos III
- European Development Regional Fund A way to achieve Europe ERDF
- Spanish Network for the Research in Infectious Diseases
- Consejeria de Innovacion
- Junta de Andalucia
Healthcare-associated infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) are a leading cause of morbidity and mortality worldwide. These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions aimed at reducing the transmission of MDR-GNB. The recommendations are stratified by type of infection prevention and control intervention and species of MDR-GNB and are presented in the form of basic' practices, recommended for all acute care facilities, and additional special approaches' to be considered when there is still clinical and/or epidemiological and/or molecular evidence of ongoing transmission, despite the application of the basic measures. The level of evidence for and strength of each recommendation, were defined according to the GRADE approach.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据